Skip to main content
logo
Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
2.050
-0.040 (-1.91%)
At close: Jul 28, 2026, 4:00 PM EDT
2.050
0.00 (0.00%)
After-hours: Jul 28, 2026, 4:10 PM EDT

Century Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0109.166.592.245.2-
Revenue Growth
-1556.76%194.81%-57.01%--
Gross Profit
0109.166.592.245.2-
Operating Income
-115.12-17.27-138.14-146.55-133.83-94.88
Net Income
-107.78-9.58-126.57-136.67-130.93-95.82
Earnings Per Share
-1.14-0.14-1.61-2.30-2.27-2.96
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
134.8117.11189.29172.74315.5222.88
Total Debt
43.9440.2448.9646.6648.9424.5
Net Cash (Debt)
90.8676.87140.33126.08266.56198.38
Net Cash Growth
-22.56%-45.22%11.30%-52.70%34.37%264.41%
Net Cash Per Share
0.800.891.782.134.626.12

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-94.52-103.88-110.14-88.3514.05-89
Capital Expenditures
-0.96-0.85-0.15-13.74-30.6-44.97
Free Cash Flow
-95.47-104.72-110.29-102.08-16.55-133.97
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-100.00%100.00%100.00%100.00%-
Operating Margin
--15.82%-2096.48%-6556.87%-2574.17%-
Pretax Margin
--8.84%-1893.70%-6030.96%-2516.66%-
Profit Margin
--8.78%-1920.87%-6115.12%-2518.41%-
FCF Margin
--95.93%-1673.84%-4567.52%-318.37%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
-0.8013.1689.6357.70-